These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 27253830)

  • 21. Synthesis of novel 1H-Pyrazolo[3,4-b]pyridine derivatives as DYRK 1A/1B inhibitors.
    Park A; Hwang J; Lee JY; Heo EJ; Na YJ; Kang S; Jeong KS; Kim KY; Shin SJ; Lee H
    Bioorg Med Chem Lett; 2021 Sep; 47():128226. PubMed ID: 34182093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis of novel 1,2,3-triazole tagged pyrazolo[3,4-b]pyridine derivatives and their cytotoxic activity.
    Kurumurthy C; Veeraswamy B; Sambasiva Rao P; Santhosh Kumar G; Shanthan Rao P; Loka Reddy V; Venkateswara Rao J; Narsaiah B
    Bioorg Med Chem Lett; 2014 Feb; 24(3):746-9. PubMed ID: 24424132
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, synthesis and biological evaluation of certain CDK2 inhibitors based on pyrazole and pyrazolo[1,5-a] pyrimidine scaffold with apoptotic activity.
    Ali GME; Ibrahim DA; Elmetwali AM; Ismail NSM
    Bioorg Chem; 2019 May; 86():1-14. PubMed ID: 30682722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis of novel hydrazone and azole functionalized pyrazolo[3,4-b]pyridine derivatives as promising anticancer agents.
    Nagender P; Naresh Kumar R; Malla Reddy G; Krishna Swaroop D; Poornachandra Y; Ganesh Kumar C; Narsaiah B
    Bioorg Med Chem Lett; 2016 Sep; 26(18):4427-4432. PubMed ID: 27528432
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New pyrazolopyridine analogs: Synthesis, antimicrobial, antiquorum-sensing and antitumor screening.
    El-Gohary NS; Shaaban MI
    Eur J Med Chem; 2018 May; 152():126-136. PubMed ID: 29702448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design, synthesis, biological evaluation and molecular modeling of novel 1H-pyrrolo[2,3-b]pyridine derivatives as potential anti-tumor agents.
    Wang R; Chen Y; Yang B; Yu S; Zhao X; Zhang C; Hao C; Zhao D; Cheng M
    Bioorg Chem; 2020 Jan; 94():103474. PubMed ID: 31859010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, synthesis and biological evaluation of novel pyridine-thiazolidinone derivatives as anticancer agents: Targeting human carbonic anhydrase IX.
    Ansari MF; Idrees D; Hassan MI; Ahmad K; Avecilla F; Azam A
    Eur J Med Chem; 2018 Jan; 144():544-556. PubMed ID: 29289880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design, synthesis and biological evaluation of 1H-pyrrolo[2,3-b]pyridine and 1H-pyrazolo[3,4-b]pyridine derivatives as c-Met inhibitors.
    Liu N; Wang Y; Huang G; Ji C; Fan W; Li H; Cheng Y; Tian H
    Bioorg Chem; 2016 Apr; 65():146-58. PubMed ID: 26950400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanistic selectivity investigation and 2D-QSAR study of some new antiproliferative pyrazoles and pyrazolopyridines as potential CDK2 inhibitors.
    Hassan GS; Georgey HH; Mohammed EZ; George RF; Mahmoud WR; Omar FA
    Eur J Med Chem; 2021 Jun; 218():113389. PubMed ID: 33784602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and in vitro antiproliferative activity of certain novel pyrazolo[3,4-b]pyridines with potential p38α MAPK-inhibitory activity.
    Farahat AA; Samir EM; Zaki MY; Serya RAT; Abdel-Aziz HA
    Arch Pharm (Weinheim); 2022 Feb; 355(2):e2100302. PubMed ID: 34796536
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis, biological evaluation, and molecular docking studies of N-((1,3-diphenyl-1H-pyrazol-4-yl)methyl)aniline derivatives as novel anticancer agents.
    Huang XF; Lu X; Zhang Y; Song GQ; He QL; Li QS; Yang XH; Wei Y; Zhu HL
    Bioorg Med Chem; 2012 Aug; 20(16):4895-900. PubMed ID: 22819191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibacterial profile against drug-resistant Staphylococcus epidermidis clinical strain and structure-activity relationship studies of 1H-pyrazolo[3,4-b]pyridine and thieno[2,3-b]pyridine derivatives.
    Leal B; Afonso IF; Rodrigues CR; Abreu PA; Garrett R; Pinheiro LC; Azevedo AR; Borges JC; Vegi PF; Santos CC; da Silveira FC; Cabral LM; Frugulhetti IC; Bernardino AM; Santos DO; Castro HC
    Bioorg Med Chem; 2008 Sep; 16(17):8196-204. PubMed ID: 18701299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis and evaluation of novel 2-(1H-imidazol-2-yl) pyridine Sorafenib derivatives as potential BRAF inhibitors and anti-tumor agents.
    Jiao Y; Xin BT; Zhang Y; Wu J; Lu X; Zheng Y; Tang W; Zhou X
    Eur J Med Chem; 2015 Jan; 90():170-83. PubMed ID: 25461318
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anticancer profile and anti-inflammatory effect of new N-(2-((4-(1,3-diphenyl-1H-pyrazol-4-yl)pyridine sulfonamide derivatives.
    Abdel-Maksoud MS; Mohamed Hassan R; Abdel-Sattar El-Azzouny A; Nabil Aboul-Enein M; Oh CH
    Bioorg Chem; 2021 Dec; 117():105424. PubMed ID: 34678604
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, synthesis, biological evaluation and molecular modeling of dihydropyrazole sulfonamide derivatives as potential COX-1/COX-2 inhibitors.
    Chen Z; Wang ZC; Yan XQ; Wang PF; Lu XY; Chen LW; Zhu HL; Zhang HW
    Bioorg Med Chem Lett; 2015 May; 25(9):1947-51. PubMed ID: 25866240
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis, antitumor evaluation and microarray study of some new pyrazolo[3,4-d][1,2,3]triazine derivatives.
    Nasr T; Bondock S; Youns M; Fayad W; Zaghary W
    Eur J Med Chem; 2017 Dec; 141():603-614. PubMed ID: 29107422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and evaluation of pyrazolo[3,4-b]pyridine CDK1 inhibitors as anti-tumor agents.
    Lin R; Connolly PJ; Lu Y; Chiu G; Li S; Yu Y; Huang S; Li X; Emanuel SL; Middleton SA; Gruninger RH; Adams M; Fuentes-Pesquera AR; Greenberger LM
    Bioorg Med Chem Lett; 2007 Aug; 17(15):4297-302. PubMed ID: 17532631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, synthesis and biological evaluation of novel pyrazoline-containing derivatives as potential tubulin assembling inhibitors.
    Qin YJ; Li YJ; Jiang AQ; Yang MR; Zhu QZ; Dong H; Zhu HL
    Eur J Med Chem; 2015 Apr; 94():447-57. PubMed ID: 25828827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis of novel ethyl 2,4-disubstituted 8-(trifluoromethyl)pyrido[2',3':3,4]pyrazolo[1,5-a]pyrimidine-9-carboxylate derivatives as promising anticancer agents.
    Ravi Kumar N; Poornachandra Y; Krishna Swaroop D; Jitender Dev G; Ganesh Kumar C; Narsaiah B
    Bioorg Med Chem Lett; 2016 Nov; 26(21):5203-5206. PubMed ID: 27720296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New imidazo[1,2-b]pyrazoles as anticancer agents: synthesis, biological evaluation and structure activity relationship analysis.
    Grosse S; Mathieu V; Pillard C; Massip S; Marchivie M; Jarry C; Bernard P; Kiss R; Guillaumet G
    Eur J Med Chem; 2014 Sep; 84():718-30. PubMed ID: 25064349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.